Live
FierceBiotechRelay ‘full steam ahead’ on PI3K inhibitor fueled by first phase 2 data in blood vessel disorderEndpoints NewsBioMarin's rare disease therapy shows no clinical benefit in Phase 3 testClinical OMICsFDA-Approved Asthma Drug Boosts Efficacy of Immunotherapy in Aggressive CancersEdwards LifesciencesEdwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd - AD HOC NEWSCharles RiverCharles River Laboratories stock (US1591881009): Fresh earnings and outlook keep investors focused o - AD HOC NEWSLonza NewsLonza Group AG stock (CH0013841017): pharma supplier in focus after 2025 results and dividend decisi - AD HOC NEWSLabCorpLabcorp stock (US50540R4092): Q1 results, new contracts and healthcare demand in focus - AD HOC NEWSQiagenQiagen N.V. stock (NL0012169213): diagnostics specialist updates investors after Q1 results - AD HOC NEWSWuXi AppTecWuXi AppTec Supports a More Connected Life Sciences Ecosystem Through Collaboration - IssuewireAmgenBiopharma bites: IRA is here to stay, plus more safety concerns for Amgen's Tavneos - FirstWord Pharma10x Genomics NewsThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - AOL.comMettler ToledoMettler-Toledo stock (US5926881054): Q1 results and guidance reset grab Wall Street's attention - AD HOC NEWS
Agilent Feb 12, 2026

Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net

Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net

Original
Body unavailable. Use the original source.